A post-hoc analysis of the pivotal CANVAS trial shows those receiving higher dose canagliflozin are more likely to experience ...

Olema Pharmaceuticals has announced that it has selected a 90 mg dosage of palazestrant for the second part of its Phase 3 OPERA-01 monotherapy trial and also for the OPERA-02 combination trial ...

Nervigesic 300mg Capsule is an antiepileptic medication. When given for epilepsy, it is believed to work by reducing the abnormal electrical activity in the brain, thus preventing seizures. It is also ...

Since then, the e-pharmacy firm has raised only $40 million, through a rights issue from Tata Digital in 2022. The planned $300 million external fundraising for 1mg marks a shift in strategy for the ...